2,757
Views
18
CrossRef citations to date
0
Altmetric
Reports

Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor

, , , , , & show all
Pages 536-549 | Received 21 Oct 2016, Accepted 20 Dec 2016, Published online: 03 Feb 2017

References

  • Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132:2131-57; PMID:17498508; http://dx.doi.org/10.1053/j.gastro.2007.03.054
  • McIntosh CHS, Widenmaier S, Kim S-J. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). Vitam Horm 2009; 80:409-71; PMID:19251046; http://dx.doi.org/10.1016/S0083-6729(08)00615-8
  • Christensen M, Vedtofte L, Holst JJ, Vilsbøll T, Knop FK. Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans. Diabetes 2011; 60:3103-9; PMID:21984584; http://dx.doi.org/10.2337/db11-0979
  • Irwin N, Gault V, Flatt PR. Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease? Expert Opin Investig Drugs 2010; 19:1039-48; PMID:20698813; http://dx.doi.org/10.1517/13543784.2010.513381
  • Flatt PR. Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes? Diabet Med 2008; 25:759-64.; PMID: 18513308; http://dx.doi.org/10.1111/j.1464-5491.2008.02455.x
  • Meier JJ, Nauck MA, Schmidt WE, Gallwitz B. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul Pept 2002; 107:1-13; PMID:12137960; http://dx.doi.org/10.1016/S0167-0115(02)00039-3
  • Nauck MA, Baller B, Meier JJ. Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes 2004; 53(Suppl 3):S190-6; PMID:15561910; http://dx.doi.org/10.2337/diabetes.53.suppl_3.S190
  • Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 1993; 133:2861-70; PMID:8243312; http://dx.doi.org/10.1210/endo.133.6.8243312
  • Cordomí A, Ismail S, Matsoukas M-T, Escrieut C, Gherardi M-J, Pardo L, Fourmy D. Functional elements of the gastric inhibitory polypeptide receptor: Comparison between secretin- and rhodopsin-like G protein-coupled receptors. Biochem Pharmacol 2015; 96:237-46; PMID:26043830; http://dx.doi.org/10.1016/j.bcp.2015.05.015
  • Miller LJ, Dong M, Harikumar KG, Gao F. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor. Biochem Soc Trans 2007; 35:709-12; PMID:17635130; http://dx.doi.org/10.1042/BST0350709
  • Hollenstein K, de Graaf C, Bortolato A, Wang M-W, Marshall FH, Stevens RC. Insights into the structure of class B GPCRs. Trends Pharmacol Sci 2014; 35:12-22; PMID:24359917; http://dx.doi.org/10.1016/j.tips.2013.11.001
  • Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002; 8:738-42; PMID:12068290; http://dx.doi.org/10.1038/nm727
  • Yamada C, Yamada Y, Tsukiyama K, Yamada K, Yamane S, Harada N, Miyawaki K, Seino Y, Inagaki N. Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes. Biochem Biophys Res Commun 2007; 364:175-80; PMID:17937928; http://dx.doi.org/10.1016/j.bbrc.2007.09.128
  • Pathak V, Gault VA, Flatt PR, Irwin N. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice. Mol Cell Endocrinol 2015; 401:120-9; PMID:25449420; http://dx.doi.org/10.1016/j.mce.2014.10.025
  • Gault VA, McClean PL, Cassidy RS, Irwin N, Flatt PR. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia 2007; 50:1752-62; PMID:17558485; http://dx.doi.org/10.1007/s00125-007-0710-4
  • McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab 2007; 293:E1746-55; PMID: 17848629; http://dx.doi.org/10.1152/ajpendo.00460.2007
  • Ravn P, Madhurantakam C, Kunze S, Matthews E, Priest C, O'Brien S, Collinson A, Papworth M, Fritsch-Fredin M, Jermutus L, et al. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor. J Biol Chem 2013; 288:19760-72; PMID: 23689510; http://dx.doi.org/10.1074/jbc.M112.426288
  • Hutchings CJ, Koglin M, Marshall FH. Therapeutic antibodies directed at G protein-coupled receptors. mAbs 2010; 2:594-606; PMID: 20864805; http://dx.doi.org/10.4161/mabs.2.6.13420
  • Abdiche YN, Harriman R, Deng X, Yeung YA, Miles A, Morishige W, Boustany L, Zhu L, Izquierdo SM, Harriman W. Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms. mAbs 2016; 8:264-77; PMID: 26652308; http://dx.doi.org/10.1080/19420862.2015.1118596
  • Wu L, Oficjalska K, Lambert M, Fennell BJ, Darmanin-Sheehan A, Shúilleabháin DN, et al. Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids. J Immunol 2012; 188:322-33; PMID: 22131336; http://dx.doi.org/10.4049/jimmunol.1102466
  • Liao-Chan S, Zachwieja J, Gomez S, Duey D, Lippincott J, Theunissen J-W. Monoclonal antibody binding-site diversity assessment with a cell-based clustering assay. J Immunol Methods 2014; 405:1-14; PMID: 24380699; http://dx.doi.org/10.1016/j.jim.2013.12.007
  • Suzuki R, Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 2006; 22:1540-2; PMID: 16595560; http://dx.doi.org/10.1093/bioinformatics/btl117
  • Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria, 2015.
  • Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23:2947-8; PMID: 17846036; http://dx.doi.org/10.1093/bioinformatics/btm404
  • Mettler Izquierdo S, Varela S, Park M, Collarini EJ, Lu D, Pramanick S, Rucker J, Lopalco L, Etches R, Harriman W. High-efficiency antibody discovery achieved with multiplexed microscopy. Microscopy (Oxford, England) 2016; 65:341-52; PMID:27107009; http://dx.doi.org/10.1093/jmicro/dfw014
  • Baek DS, Kim YS. Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif. Biochem Biophys Res Commun 2015; 463:414-20; PMID: 26036575; http://dx.doi.org/10.1016/j.bbrc.2015.05.086
  • Townsend S, Fennell BJ, Apgar JR, Lambert M, McDonnell B, Grant J, Wade J, Franklin E, Foy N, Ní Shúilleabháin D, et al. Augmented binary substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies. Proc Natl Acad Sci U S A 2015; 112:15354-9; PMID: 26621728; http://dx.doi.org/10.1073/pnas.1510944112
  • Liu H, May K. Disulfide bond structures of IgG molecules. mAbs 2012; 4:17-23; PMID: 22327427; http://dx.doi.org/10.4161/mabs.4.1.18347
  • Liu H, Chumsae C, Gaza-Bulseco G, Hurkmans K, Radziejewski CH. Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. Anal Chem 2010; 82:5219-26; PMID: 20491447; http://dx.doi.org/10.1021/ac100575n
  • Brych SR, Gokarn YR, Hultgen H, Stevenson RJ, Rajan R, Matsumura M. Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation. J Pharm Sci 2010; 99:764-81; PMID: 19691118; http://dx.doi.org/10.1002/jps.21868
  • Hutterer KM, Hong RW, Lull J, Zhao X, Wang T, Pei R, Le ME, Borisov O, Piper R, Liu YD, et al. Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects. mAbs 2013; 5:608-13; PMID: 23751615; http://dx.doi.org/10.4161/mabs.24725
  • Van Roy M, Ververken C, Beirnaert E, Hoefman S, Kolkman J, Vierboom M, Breedveld E, 't Hart B, Poelmans S, Bontinck L, et al. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody(R) ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Res Ther 2015; 17:135; PMID:25994180; http://dx.doi.org/10.1186/s13075-015-0651-0
  • Van Heeke G, Allosery K, De Brabandere V, De Smedt T, Detalle L, de Fougerolles A. Nanobodies(R) as inhaled biotherapeutics for lung diseases. Pharmacology & Therapeutics 2017; 169:47-56; PMID:27373507; http://dx.doi.org/10.1016/j.pharmthera.2016.06.012
  • Schusser B, Collarini EJ, Yi H, Izquierdo SM, Fesler J, Pedersen D, Klasing KC, Kaspers B, Harriman WD, Van de Lavoir MC, et al. Immunoglobulin knockout chickens via efficient homologous recombination in primordial germ cells. Proc Natl Acad Sci USA 2013; 110:20170-5; PMID: 24282302; http://dx.doi.org/10.1073/pnas.1317106110
  • Leighton PA, Schusser B, Yi H, Glanville J, Harriman W. A diverse repertoire of human immunoglobulin variable genes in a chicken B cell line is generated by both gene conversion and somatic hypermutation. Front Immunol 2015; 6; PMID: 25852694; http://dx.doi.org/10.3389/fimmu.2015.00126
  • Schusser B, Yi H, Collarini EJ, Izquierdo SM, Harriman WD, Etches RJ, Leighton PA. Harnessing gene conversion in chicken B cells to create a human antibody sequence repertoire. PLoS One 2013; 8:e80108; PMID: 24278246; http://dx.doi.org/10.1371/journal.pone.0080108
  • Xu JL, Davis MM. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 2000; 13:37-45; PMID: 10933393; http://dx.doi.org/10.1016/S1074-7613(00)00006-6
  • Abdiche YN, Miles A, Eckman J, Foletti D, Van Blarcom TJ, Yeung YA, Pons J, Rajpal A. High-throughput epitope binning assays on label-free array-based biosensors can yield exquisite epitope discrimination that facilitates the selection of monoclonal antibodies with functional activity. PLoS One 2014; 9:e92451; PMID: 24651868; http://dx.doi.org/10.1371/journal.pone.0092451
  • Abdiche YN, Malashock DS, Pinkerton A, Pons J. Exploring blocking assays using Octet, ProteOn, and Biacore biosensors. Anal Biochem 2009; 386:172-80; PMID: 19111520; http://dx.doi.org/10.1016/j.ab.2008.11.038
  • Abdiche YN, Lindquist KC, Stone DM, Rajpal A, Pons J. Label-free epitope binning assays of monoclonal antibodies enable the identification of antigen heterogeneity. J Immunol Methods 2012; 382:101-16; PMID: 22609372; http://dx.doi.org/10.1016/j.jim.2012.05.010
  • Nagata S, Numata Y, Onda M, Ise T, Hahn Y, Lee B, Pastan I. Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay. J Immunol Methods 2004; 292:141-55; PMID: 15350519; http://dx.doi.org/10.1016/j.jim.2004.06.009
  • Miller PL, Wolfert RL, Diedrich G. Epitope binning of murine monoclonal antibodies by a multiplexed pairing assay. J Immunol Methods 2011; 365:118-25; PMID: 21223970; http://dx.doi.org/10.1016/j.jim.2010.12.021
  • Venneti KC, Malthouse JPG, O'Harte FPM, Hewage CM. Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide. Biochim Biophys Acta 2011; 1814:882-8; PMID: 21539943; http://dx.doi.org/10.1016/j.bbapap.2011.04.002
  • Underwood CR, Parthier C, Reedtz-Runge S. Structural basis for ligand recognition of incretin receptors. Vitam Horm 2010; 84:251-78; PMID:21094903; http://dx.doi.org/10.1016/B978-0-12-381517-0.00009-6
  • Tikhele SH, Pissurlenkar RRS, Srivastava S, Saran A, Coutinho EC. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations. J Pept Sci 2010; 16:383-91; PMID:20607844; http://dx.doi.org/10.1002/psc.1250
  • Pal K, Melcher K, Xu HE. Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Acta Pharmacol Sin 2012; 33:300-11; PMID: 22266723; http://dx.doi.org/10.1038/aps.2011.170
  • Harriman WD. Gel microdrop composition and method of using the same. Crystal Bioscience Inc., 2013.
  • Durocher Y, Loignon M. Process, Vectors and Engineered Cell Lines for Enhanced Large-Scale Transfection. 2009.